Trial Profile
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2014
Price :
$35
*
At a glance
- Drugs Carperitide (Primary)
- Indications Respiratory distress syndrome
- Focus Therapeutic Use
- Sponsors Asubio Pharmaceuticals
- 25 May 2014 New trial record